Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.amepre.2020.10.015 http://scihub22266oqcxt.onion/10.1016/j.amepre.2020.10.015 33745520!7832683!33745520     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Am+J+Prev+Med 2021 ; 60 (4): 471-477 Nephropedia Template TP {{tp|p=33745520|t=2021. Health and Institutional Risk Factors of COVID-19 Mortality in Mexico, 2020 |pdf=|usr=}}{{33745520}} gab.com Text Health and Institutional Risk Factors of COVID-19 Mortality in Mexico, 2020 JO: Am J Prev Med http://www.kidney.de/pget.php?&tw=1&pmid=33745520 #FOAvip INTRODUCTION: Several studies in developed and developing countries have analyzed the health risk factors associated with COVID-19 mortality. Comorbid diseases are a key explanatory factor behind COVID-19 mortality, but current studies treat comorbidities in isolation, at average-population values, and rarely assess how death risk varies for different health profiles across institutions. Estimating death risk variations for different interactions between comorbid diseases and across healthcare institutions is crucial to gaining a significant depth of understanding in relation to mortality during the pandemic. METHODS: This study relies on data from approximately half a million people in Mexico (of all recorded cases through August 15, 2020) and on Bayesian estimation to provide a more robust estimate of the combined effect of several comorbidities and institutional inequalities on COVID-19 mortality. RESULTS: The findings of the study illustrate the additive effects of several comorbid diseases, with the presence of obesity, diabetes, hypertension, and chronic kidney disease increasing the mortality risk of COVID-19. There are also variations in the risk of death across the heterogeneous Mexican health system. CONCLUSIONS: This study shows that COVID-19 mortality risk sharply increases in patients with 2 or more comorbid diseases (obesity, diabetes, hypertension, and cardiovascular diseases) in Mexico. However, death risk varied significantly across institutions for patients with the same comorbidity profile. Twit Text FOAVip Health and Institutional Risk Factors of COVID-19 Mortality in Mexico, 2020 ????Am J Prev Med http://www.kidney.de/pget.php?&tw=1&pmid=33745520 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33745520 #FOAvip English Wikipedia <ref>{{Cite pmid|33745520}}</ref> Health and Institutional Risk Factors of COVID-19 Mortality in Mexico, 2020 #MMPMID33745520 Najera H; Ortega-Avila AG Am J Prev Med 2021[Apr]; 60 (4): 471-477 PMID33745520show ga INTRODUCTION: Several studies in developed and developing countries have analyzed the health risk factors associated with COVID-19 mortality. Comorbid diseases are a key explanatory factor behind COVID-19 mortality, but current studies treat comorbidities in isolation, at average-population values, and rarely assess how death risk varies for different health profiles across institutions. Estimating death risk variations for different interactions between comorbid diseases and across healthcare institutions is crucial to gaining a significant depth of understanding in relation to mortality during the pandemic. METHODS: This study relies on data from approximately half a million people in Mexico (of all recorded cases through August 15, 2020) and on Bayesian estimation to provide a more robust estimate of the combined effect of several comorbidities and institutional inequalities on COVID-19 mortality. RESULTS: The findings of the study illustrate the additive effects of several comorbid diseases, with the presence of obesity, diabetes, hypertension, and chronic kidney disease increasing the mortality risk of COVID-19. There are also variations in the risk of death across the heterogeneous Mexican health system. CONCLUSIONS: This study shows that COVID-19 mortality risk sharply increases in patients with 2 or more comorbid diseases (obesity, diabetes, hypertension, and cardiovascular diseases) in Mexico. However, death risk varied significantly across institutions for patients with the same comorbidity profile. |Bayes Theorem[MESH] |COVID-19/*mortality[MESH] |Comorbidity[MESH] |Diabetes Mellitus/epidemiology[MESH] |Female[MESH] |Hospitals/*statistics & numerical data[MESH] |Humans[MESH] |Hypertension/epidemiology[MESH] |Male[MESH] |Mexico[MESH] |Middle Aged[MESH] |Models, Statistical[MESH] |Obesity/epidemiology[MESH] |Pandemics/*statistics & numerical data[MESH] |Renal Insufficiency, Chronic/epidemiology[MESH] |Risk Assessment/statistics & numerical data[MESH]Health and Institutional Risk Factors of COVID-19 Mortality in Mexico,(epmc).pdf DeepDyve Pubget Overpricing